In a recent article posted to the medRxiv* preprint server, scientists explored the coronavirus disease 2019 (COVID-19) BNT162b2 vaccine triggered non-neutralizing and neutralizing antibody functions.
Researchers have been able to directly visualize the neutral products of the mutual neutralization of hydronium and hydroxide, and report three different product channels: two channels were attributed ...
When human immunodeficiency virus (HIV) emerged and was identified as the cause of acquired immunodeficiency syndrome (AIDS), it was expected that a vaccine would be developed eventually. By over ...
Serum samples obtained from unvaccinated persons after infection with the B.1.1.7 (alpha), B.1.351 (beta), or B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...
Standing out from the crowd illustration. Businessman thinking twice about following the crowd over a cliff. Files included – jpg, ai (version 8 and CS3), svg, and eps (version 8) While common sense ...
Therefore, we administered a third 30-μg BNT162b2 dose 7.9 to 8.8 months after dose 2 to 11 participants 18 to 55 years of age and to 12 participants 65 to 85 years of age from U.S. sites in the phase ...
In a recent study posted to the bioRxiv* preprint server, scientists analyzed the antigenic characteristics of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.5 and BA.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results